|
Monday, March 24 — 8:00 AM — Virginia Suite
Click on the numbers in parentheses to display abstracts.
Section G1 - PATHOBIOLOGY
Chaired by: Stephen Peiper and Peter Argani
| 8:00 |
A New Monoclonal Antibody Recognizing Human Cancers with Amplification/Over-Expression of the Human Epidermal Growth Factor Receptor
(1353)
AA Jungbluth, E Stockert, S Huang, VP Collins, K Coplan, K Iversen, D Kolb, TJ Johns, AM Scott, WJ Gullick, G Ritter, L Cohen, MJ Scanlan, WK Cavanee, LJ Old
Ludwig Institute for Cancer Research, New York, NY, San Diego, CA and Melbourne, Australia; Addenbrooke's Hospital, Cambridge, UK; University of Kent at Canterbury, Kent, UK
|
| 8:15 |
Expression of the WNT Transduction Pathway Protein LEF-1 in Basal Cell Carcinomas and Trichoepitheliomas
(1342)
MA Arroyo, CA Lum, MM Thein, SW Binder, RK Brynes
USC-Keck School of Medicine; UCLA-Geffen School of Medicine, Los Angeles, CA
|
| 8:30 |
Molecular Cytogenetic Evaluation of Ten Uveal Melanoma Cell Lines
(1370)
JS White, RL Becker, IW McLean, J Nath, AE Director-Myska
Armed Forces Institute of Pathology, Washington, DC; West Virginia University, Morgantown, WV
|
| 8:45 |
Direct Evidence of Telomere Shortening in a Wide Range of Human Epithelial Pre-Cancerous Lesions
(1359)
AK Meeker, JL Hicks, P Argani, A Maitra, CA Iacobuzio-Donahue, EA Montgomery, WH Westra, AM De Marzo
Johns Hopkins Medical Institutions, Baltimore, MD
|
| 9:00 |
Expression of MLH1/MSH2 in Colorectal Adenocarcinomas: Sage/Microarray Profile and Tumor Phenotype
(1352)
JJ Jimenez-Martin, MT Miranda, A Blanes, SJ Diaz-Cano
University of Malaga Medical School, Malaga, Spain; Barts and the London School of Medicine, London, UK
|
| 9:15 |
Inhibition of Tumourigenicity of Prostate Cancer Cells by Suppressing Expression of Cutaneous Fatty Acid-Binding Protein (C-FABP)
(1341)
J Adamson, EA Morgan, C Beesley, Y Mei, CS Foster, P Smith, Y Ke Univ.of Liverpool,UK
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
|
|
